Abstract
1/2021
vol. 16
Guidelines/recommendations
Position statement of the Polish Society of Gastroenterology and the National Gastroenterology Consultant on vaccination against COVID-19 among patients with inflammatory bowel diseases
- Chair and Department of Gastroenterology, Dietetics and Internal Diseases, Poznan University of Medical Sciences, Swiecicki Clinical Hospital, Poznan, Poland
- Department of Internal Diseases and Gastroenterology with Subdivision for the Treatment of Non-Specific Inflammatory Bowel Diseases, Central Clinical Hospital of the Ministry of the Interior and Administration, Warsaw, Poland
- Department of Gastroenterological Oncology, Sklodowska-Curie National Research Institute of Oncology, Warsaw, Poland
- Collegium Medicum, Jan Kochanowski University, Kielce, Poland
Gastroenterology Rev 2021; 16 (1): 2–4
Online publish date: 2021/02/15
The COVID-19 (coronavirus disease 2019) pandemic significantly impacted the functioning of the whole world, both with regard to health, society, and economics. It is the greatest civilizational challenge for humanity since World War II. So far, more than 80 million SARS-CoV-2 (severe acute respiratory syndrome coronavirus-2) infections have been reported, and nearly 2 million people have died from this infectious disease (as of 4.01.2021) [1]. However, accurate statistics on the number of patients in whom infection did not lead to death but caused significant organ complications are unknown. The long-term effects of infection with the new coronavirus species also remain unelucidated.
Coverage in
Indexed in
Integrated with
